ArticleAnti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?
Section snippets
Sharon Lie Fong graduated from the Faculty of Medicine at the Catholic University of Leuven, Belgium. She started her career in 2002 as a junior resident in the Department of Obstetrics and Gynaecology, Erasmus MC University Medical Centre at Rotterdam, the Netherlands. After three years, she joined the Division of Reproductive Medicine there to work on her PhD thesis focusing on clinical aspects of anti-Müllerian hormone.
References (27)
- et al.
Antimullerian hormone serum levels: a putative marker for ovarian aging
Fertility and Sterility
(2002) - et al.
Early follicular antimullerian hormone as an indicator of ovarian reserve
Fertility and Sterility
(2006) - et al.
Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol
Fertility and Sterility
(2004) - et al.
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial
Lancet
(2007) - et al.
Implantation rates after in-vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of culture
Fertility and Sterility
(2000) - et al.
TGF-beta family members and gonadal development
Trends in Endocrinology and Metabolism
(1999) Chromosome abnormalities and their relationship to morphology and development of human embryos
Reproductive BioMedicine Online
(2006)- et al.
Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles
Fertility and Sterility
(2002) - et al.
Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in-vitro fertilization or intracytoplasmic sperm injection
Fertility and Sterility
(2007) - et al.
Antimullerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization
Fertility and Sterility
(2008)
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study
Fertility Sterility
Anti-Mullerian hormone and folliculogenesis
Molecular and Cellular Endocrinology
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial
Human Reproduction
Cited by (0)
Sharon Lie Fong graduated from the Faculty of Medicine at the Catholic University of Leuven, Belgium. She started her career in 2002 as a junior resident in the Department of Obstetrics and Gynaecology, Erasmus MC University Medical Centre at Rotterdam, the Netherlands. After three years, she joined the Division of Reproductive Medicine there to work on her PhD thesis focusing on clinical aspects of anti-Müllerian hormone.
Declaration: The authors report no financial or commercial conflicts of interest.